Raw Material



It is moderate efficacy antihypertensive; primarily decreases total peripheral resistance with little effect on cardiac output.
Methyldopa is a competitive inhibitor of the enzyme aromatic L-amino acid decarboxylase (DOPA decarboxylase) which is responsible for conversion of L-Dopa into dopamine.
It is also converted α-methylnorepinephrine by dopamine β-hydroxylase.


Mild to moderate hypertension etc.

Side Effects: 

Sedation, lethargy, reduced mental capacity, dry mouth, fluid retention, nasal congestion etc.

Dosage Forms:

Methyldopa 250 mg tablets


Brand Names (Company Name):

Methyl Dopa (Unicure (India) Pvt.Ltd.)

Aldopam (Neon Labs)
Alphadopa (Wockhardt (Merind))
Dopagyt (Themis Pharma)
Emdopa (IDPL)
Gynapres (Mankind)
Sembrina (Sanofi Aventis) 

About Author

Full Time Blogger, Part Time Entrepreneur and Partial Time Helper for New Start-UP's in Pharmaceutical, Ayurvedic and Nutraceutical Sector. Contact him at pharmafranchiseehelp@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: